These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28830058)

  • 1. Contrast-enhanced ultrasonography of the liver using SonoVue.
    Ferraioli G; Meloni MF
    Ultrasonography; 2018 Jan; 37(1):25-35. PubMed ID: 28830058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
    Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
    J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial.
    Wang WP; Wu Y; Luo Y; Li R; Zhou XD; Zhang J; Qian CW; Tan XY; Xu QH; Wang Y; Yuan JJ
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):370-6. PubMed ID: 19666405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of real-time three-dimensional contrast-enhanced ultrasound using SonoVue for the evaluation of focal liver lesions: a prospective single-center study.
    Lu Y; Liu B; Zheng Y; Luo J; Zhang X; Huang G; Xie X; Ye J; Wang W; Liu X; Xie X
    Am J Transl Res; 2018; 10(5):1469-1480. PubMed ID: 29887960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shear-wave elastography combined with contrast-enhanced ultrasound algorithm for noninvasive characterization of focal liver lesions.
    Ruan SM; Huang H; Cheng MQ; Lin MX; Hu HT; Huang Y; Li MD; Lu MD; Wang W
    Radiol Med; 2023 Jan; 128(1):6-15. PubMed ID: 36525179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can contrast-enhanced ultrasonography characterize focal liver lesions and differentiate between benign and malignant, thus providing a one-stop imaging service for patients?().
    Cokkinos DD; Blomley MJ; Harvey CJ; Lim A; Cunningham C; Cosgrove DO
    J Ultrasound; 2007 Dec; 10(4):186-93. PubMed ID: 23396623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?
    Dai Y; Chen MH; Yin SS; Yan K; Fan ZH; Wu W; Wang YB; Yang W
    Invest Radiol; 2007 Aug; 42(8):596-603. PubMed ID: 17620943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of contrast-enhanced ultrasound in China.
    Xu HX; Lu MD
    J Med Ultrason (2001); 2010 Jul; 37(3):97-106. PubMed ID: 27278008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indeterminate focal liver lesions incidentally discovered at gray-scale US: role of contrast-enhanced sonography.
    Bartolotta TV; Taibbi A; Midiri M; Matranga D; Solbiati L; Lagalla R
    Invest Radiol; 2011 Feb; 46(2):106-15. PubMed ID: 20938345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
    Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
    J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions - A retrospective analysis of 83 cases.
    Dong FJ; Xu JF; Du D; Jiao Y; Zhang L; Li M; Liu HY; Xiong Y; Luo H
    Ultrasonics; 2016 Aug; 70():221-6. PubMed ID: 27235776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound.
    Solbiati L; Ierace T; Tonolini M; Cova L
    Eur J Radiol; 2004 Jun; 51 Suppl():S19-23. PubMed ID: 15311434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.